Literature DB >> 23804478

A case of heterotopic heart transplant as a "biologic left ventricular assist" in restrictive cardiomyopathy.

Hannah Copeland1, Nishant Kalra, Monica Gustafson, Romana Coehlo-Anderson, Mark Friedman, Jack G Copeland.   

Abstract

Heterotopic heart transplant (HHT) has traditionally been thought of as creating 2 parallel circulations. We present a case of using the donor heart as a "biologic left ventricular assist" (bio-LVA). The heterotopic technique used consisted of 4 anastomoses: the donor heart pulmonary artery (PA) to the native heart right atrium, the superior vena cava to superior vena cava, the left atrium to left atrium, and the aorta to aorta. A 9-year-old boy with restrictive cardiomyopathy, a PA pressure of 85/53 mmHg, received a HHT because he would probably not be able to tolerate an orthotopic heart transplant secondary to elevated PA pressure. He is currently alive 14 years post-transplantation.

Entities:  

Keywords:  cardiomyopathy; heart; heart failure; pediatric; pulmonary vascular resistance/hypertension; transplantation

Year:  2011        PMID: 23804478     DOI: 10.1177/2150135111411588

Source DB:  PubMed          Journal:  World J Pediatr Congenit Heart Surg        ISSN: 2150-1351


  2 in total

1.  The Man with 2 Hearts: 25 Years from Heterotopic to Orthotopic Heart Transplantation.

Authors:  Elizabeth L Godfrey; Michael L Kueht; Abbas Rana; O H Frazier
Journal:  Tex Heart Inst J       Date:  2019-06-01

Review 2.  Heterotopic heart transplant: relevance as Bio-VAD in emerging economies.

Authors:  Prashant Vaijyanath
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.